Dr. Reddy’s Laboratories said that it has launched Posaconazole Delayed-Release Tablets, 100 mg, a triazole antifungal drug, in the US market.

Posaconazole Delayed-Release Tablets is the therapeutic generic equivalent to NOXAFIL (posaconazole) Delayed-Release Tablets, 100 mg, which has approval from the US Food and Drug Administration.

According to IQVIA, the NOXAFIL brand and generic had sales of nearly $140.8 million MAT in the US for the most recent 12 months ending in February 2022.

Dr. Reddy’s Posaconazole Delayed-Release Tablets have been launched in 100 mg strength in bottle count sizes of 60.

  Dr. Reddy’s Laboratories, NOXAFIL, Posaconazole, US Food and Drug Administration, USA